NuVasive (Nasdaq:NUVA) and Globus Medical (NYSE:GMED) both saw shareholders approve their proposed merger yesterday. In February, the companies announced an agreement to combine in an all-stock transaction. The deal values NuVasive at $3.1 billion, with Globus shareholders owning roughly three-fourths of the newly merged company. BTIG analysts raised the question of potential anti-trust challenges for the deal. […]
Nuvasive
NuVasive expands indications of limb lengthening system to include pediatrics
NuVasive this week announced it received FDA 510(k) clearance for the use of its Precice all-internal limb lengthening solution for pediatric patients. Precice is a magnetically adjustable technology that uses an external remote to non-invasively lengthen implants. The system’s nail has been implanted more than 15,000 times by more than 2,000 surgeons. “Precice has over […]
NuVasive misses overall estimates on Wall Street
Nuvasive (Nasdaq:NUVA) this week posted fourth-quarter results that missed overall estimates on Wall Street. The San Diego-based orthopedic company reported profits of $24.1 million, or 42¢ per share, on sales of $305.5 million, for the three months ended Dec. 31, 2022, on sales growth of 1.12% compared to Q4 2021. It also had a profit […]
FDA clears expanded use for NuVasive C360 portfolio
NuVasive (Nasdaq:NUVA) announced today that it received FDA 510(k) clearance for use of its Modulus Cervical interbody implant with a bone void filler. The expanded indication creates new offerings in the cervical segment to surgeons and hospitals. It also further enhances the company’s C360 portfolio, according to a news release. “We believe that delivering differentiated […]
Could 2023 be a boom year for orthopedic devices?
The orthopedic devices market is expected to reach nearly $50 billion this year as procedures bounce back from COVID-19, according to GlobalData. GlobalData predicts the orthopedic surgical robotics space will be even hotter this year, growing 25.6% year-over-year to $984 million. “Boosted by artificial intelligence (AI) and machine learning, new generations of orthopedic robots are […]
Globus Medical, NuVasive to merge to form global musculoskeletal company
Globus Medical (NYSE:GMED) and NuVasive (Nasdaq:NUVA) today announced an agreement to combine in an all-stock transaction. The deal values NuVasive at $3.1 billion, with Globus shareholders owning roughly three-fourths of the newly merged company. BTIG analysts raised the question of potential anti-trust challenges for the deal, which would create the second-largest spine tech company behind […]
Analysts downgrade NuVasive stock
Needham analysts wrote today that they downgraded NuVasive (Nasdaq:NUVA) stock ahead of a potentially slow start to 2023. Analysts Davis Saxon, Mike Matson and Joseph Conway contributed to the Needham report. They switched NuVasive from a “Buy” to a “Hold” rating. The analysts explained their belief that NuVasive’s key launches “could begin to slow” in […]
NuVasive reports mixed Q3 results, reduces guidance
NuVasive (Nasdaq:NUVA) reported third-quarter results that beat on EPS but missed on revenue, reducing its guidance amid macroeconomic headwinds. Investors reacted to yesterday evening’s news by sending NUVA shares down more than 1% to 36.84 apiece in morning trading today. MassDevice‘s MedTech 100 Index, which includes stocks of the world’s largest medical device companies, was up […]
Former NuVasive executive takes corner office at LimaCorporate
LimaCorporate announced today that its board of directors appointed former NuVasive executive Massimo Calafiore as its new CEO. Calafiore resigned as NuVasive’s chief commercial officer last month. He also served as an EVP at the orthopedic device company before his departure. Before serving as EVP and CCO, Calafiore oversaw NuVasive’s product marketing and commercial functions. […]
The 10 largest orthopedic device companies in the world
Stryker, Johnson & Johnson’s DePuy Synthes and Zimmer Biomet are the largest orthopedic device companies. With elective procedure numbers rebounding after the darkest days of the COVID-19 pandemic, sales at most of the world’s largest orthopedic device companies increased by double-digit percentages during their most recent fiscal years. Here are the world’s 10 largest orthopedic […]
NuVasive chief commercial officer Massimo Calafiore is stepping down
NuVasive this week announced chief commercial officer Massimo Calafiore is resigning, effective August 31. Upon his resignation, Calafiore’s responsibilities will be reallocated among the executive management team while the company aligns its commercial structure. “On behalf of the NuVasive team, I would like to thank Massimo for his impact on our organization,” CEO Chris Barry […]
